Threebrooks Therapeutics Overview

  • Year Founded
  • 2022

Year Founded

  • Status
  • Private

  • Employees
  • 10

Employees

  • Latest Deal Type
  • Seed

  • Latest Deal Amount
  • $4.05M

  • Investors
  • 3

Threebrooks Therapeutics General Information

Description

Developer of neurodegenerative disease therapeutics and electrophysiology services designed to support brain disease research and drug development. The company offers ion channel modulating drug development, electrophysiology testing, patch clamp analysis, research services, and technology licensing activities, enabling pharmaceutical, biotechnology, and research organizations to evaluate therapeutic candidates and advance neurological disease research.

Contact Information

Website
www.threebrooks.net
Ownership Status
Privately Held (backing)
Financing Status
Venture Capital-Backed
Corporate Office
  • Rooms 320, 321, Cell Membrane Protein Research Institute
  • 66-1, Convergence Technology Road, Heunghae-eup, Buk-gu
  • Pohang, Gyeongbuk
  • South Korea
+82
Primary Industry
Drug Discovery
Other Industries
Biotechnology
Vertical(s)
Life Sciences
Corporate Office
  • Rooms 320, 321, Cell Membrane Protein Research Institute
  • 66-1, Convergence Technology Road, Heunghae-eup, Buk-gu
  • Pohang, Gyeongbuk
  • South Korea
+82

Want detailed data on 11M+ companies?

What you see here scratches the surface

Request a free trial

Want to dig into this profile?

We’ll help you find what you need

Learn more

Threebrooks Therapeutics Valuation & Funding

Deal Type Date Amount Raised to Date Post-Val Status Stage
2. Seed Round 15-Oct-2026 $4.05M Completed Pre-Clinical Trials
1. Accelerator/Incubator Completed Pre-Clinical Trials
To view Threebrooks Therapeutics’s complete valuation and funding history, request access »

Threebrooks Therapeutics Signals

Growth Rate

Weekly
Growth
Weekly Growth

Size Multiple

Median
Size Multiple

Key Data Points

Similarweb Unique Visitors

Majestic Referring Domains

PitchBook’s non-financial metrics help you gauge a company’s traction and growth using web presence and social reach.

Request a free trial

Threebrooks Therapeutics Investors (3)

Investor Name Investor Type Holding Investor Since Participating Rounds
BNH Investment Venture Capital Minority
FuturePlay Venture Capital Minority
Myriad Life Sciences Accelerator/Incubator
To view Threebrooks Therapeutics’s complete investors history, request access »

Ready to get started?

Request a free trial

Threebrooks Therapeutics FAQs

  • When was Threebrooks Therapeutics founded?

    Threebrooks Therapeutics was founded in 2022.

  • Where is Threebrooks Therapeutics headquartered?

    Threebrooks Therapeutics is headquartered in Pohang, South Korea.

  • What is the size of Threebrooks Therapeutics?

    Threebrooks Therapeutics has 10 total employees.

  • What industry is Threebrooks Therapeutics in?

    Threebrooks Therapeutics’s primary industry is Drug Discovery.

  • Is Threebrooks Therapeutics a private or public company?

    Threebrooks Therapeutics is a Private company.

  • What is Threebrooks Therapeutics’s current revenue?

    The current revenue for Threebrooks Therapeutics is .

  • How much funding has Threebrooks Therapeutics raised over time?

    Threebrooks Therapeutics has raised $4.05M.

  • Who are Threebrooks Therapeutics’s investors?

    BNH Investment, FuturePlay, and Myriad Life Sciences have invested in Threebrooks Therapeutics.

Data Transparency

  • Meet our data hygiene team

    Discover how our experts ensure you’re getting the most accurate financial data in the industry.

    Read more

  • How PitchBook sources data

    Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.

    Discover our process